Clinical Lipidology: A Companion to Braunwald’s Heart Disease

★★★★★ 4.5 70 reviews

US$41.10
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by www.lusorealestategroup.com
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
US$41.10
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives Sep 7
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by www.lusorealestategroup.com
Free 30-day returns Details

Product details

Management number 231841702 Release Date 2026/06/18 List Price US$41.10 Model Number 231841702
Category

Part of the renowned Braunwald family of references, Clinical Lipidology: A Companion to Braunwald’s Heart Disease provides today’s clinicians with clear, authoritative guidance on the therapeutic management of patients with high cholesterol levels and other atherogenic lipid disorders. An invaluable resource for cardiologists, lipidologists, endocrinologists, and internal medicine physicians, this one-stop reference covers everything from basic science and the pathogenesis of atherothrombotic disease to risk assessment and the latest therapy options. Now fully updated from cover to cover, the 3rd Edition offers unparalleled coverage of lipidology in an accessible and user-friendly manner.Thoroughly covers the assessment, diagnosis, and treatment of patients with elevated levels of lipids and lipoproteins, including all the latest research-based recommendations, therapeutic breakthroughs, and related clinical advancesPresents the latest data on clinical guidelines, risk assessments, and established and emerging pharmacologic and nonpharmacologic therapies―all from internationally recognized experts in the fieldFeatures condensed, streamlined content that focuses on clinical applications and applying concepts to the practice setting. Chapters have now been completely reorganized into sections on risk assessment; therapy; new and evolving therapeutic targets and platforms; and special populationsIncludes new chapters on Polygenic Risk Scores; Inclisiran; Bempedoic Acid; Selective Peroxisome Proliferator–Activated Receptor–α Modulator: Pemafibrate; Evolving Therapeutic Targets: Lp(a), ANGPTL3, and ApoC-III; New Therapeutic Platforms: Gene Therapy and Genome Editing; and moreContains new or expanded content on inflammation; genetic testing; troponins for risk assessment; statins and role of bile acid sequestrants, niacin, and fibrates; mAbs; CANTOS and CIRT; colchicine; IL-6; and cellular, molecular, and genetic therapyProvides treatment algorithms throughout, as well as case vignettes that highlight the most common clinical questions in each chapterIncorporates the latest guidelines from the AHA, ACC, ESC, and EAS, as well as future directions for ongoing research and emerging applicationsEnhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices Read more

ISBN10 0323882862
ISBN13 978-0323882866
Edition 3rd
Language English
Publisher Elsevier
Dimensions 8.86 x 0.87 x 11.14 inches
Item Weight 7.6 ounces
Print length 432 pages
Part of series Companion to Braunwald's Heart Disease
Publication date April 27, 2023

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

4.5 out of 5
★★★★★
70 ratings | 29 reviews
How item rating is calculated
View all reviews
5 stars
83% (58)
4 stars
4% (3)
3 stars
2% (1)
2 stars
1% (1)
1 star
10% (7)
Sort by

There are currently no written reviews for this product.